NCT03526250 2024-11-01Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)National Cancer Institute (NCI)Phase 2 Completed23 enrolled 11 charts
NCT04129151 2024-08-01Palbociclib + Ganitumab In Ewing SarcomaDana-Farber Cancer InstitutePhase 2 Terminated10 enrolled 15 charts
NCT01209598 2017-11-06PD0332991 (Palbociclib) in Patients With Advanced or Metastatic LiposarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Completed90 enrolled 7 charts
NCT01227434 2015-07-17PD0332991University of California, San FranciscoPhase 2 Terminated23 enrolled 8 charts